Literature DB >> 24287045

Preparing breast cancer patients for survivorship (PREP) - a pilot study of a patient-centred supportive group visit intervention.

Joanne Thompson1, Rob Coleman2, Brigitte Colwell3, Jenny Freeman4, Diana Greenfield2, Karen Holmes5, Nigel Mathers3, Malcolm Reed6.   

Abstract

PURPOSE: The process of breast cancer follow-up has psychosocial benefits for patients, notably reassurance, although attending hospital appointments can increase anxiety. Discharge from hospital follow-up can also invoke anxiety as many patients seek reassurance from continued specialist follow-up. Inevitably, due to increased survival and associated resource issues, opportunities for follow-up and support will be reduced. We delivered and evaluated an intervention which supported the transition from cancer patient to cancer survivor, for breast cancer patients being discharged to primary care.
METHODS: We delivered and evaluated a pilot of a patient-centred group intervention 'Preparing Patients for Discharge', aimed at reducing distress. Between January and September 2008, 172 participants were recruited and 74 (43%) expressed an interest in participating in the intervention; 32 of 74 took part, and participated in its evaluation using a semi-structured evaluation questionnaire, standardized measures [Hospital Anxiety and Depression Scale (HADS) and Clinical Outcomes for Routine Evaluation (CORE)] and independent qualitative interviews.
RESULTS: The qualitative analysis of questionnaire data indicated key factors were 1) shared experience, 2) support and reassurance, and 3) positive views about cancer and being discharged. The interview data revealed that the intervention enabled participants to: share experiences, focus on emotional needs, and have open discussions about recurrence, while increasing confidence in being discharged and using alternative support services. However, no significant differences were found in pre-post-interventions scores of HADS and CORE.
CONCLUSIONS: Providing a structured group intervention approach for breast cancer patients offers an early opportunity to support cancer survivors and facilitate and encourage self-management.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast; Cancer; Follow-up; Group visit intervention; Oncology; Self-management

Mesh:

Year:  2013        PMID: 24287045     DOI: 10.1016/j.ejon.2013.10.004

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  5 in total

Review 1.  Health Social Media and Patient-Centered Care: Buzz or Evidence? Findings from the Section "Education and Consumer Health Informatics" of the 2015 Edition of the IMIA Yearbook.

Authors:  P Staccini; L Fernandez-Luque
Journal:  Yearb Med Inform       Date:  2015-08-13

Review 2.  Cancer survivors' perspectives on adjustment-focused self-management interventions: a qualitative meta-synthesis.

Authors:  Laura Coffey; Orla Mooney; Simon Dunne; Linda Sharp; Aileen Timmons; Deirdre Desmond; Eleanor O'Sullivan; Conrad Timon; Rachael Gooberman-Hill; Pamela Gallagher
Journal:  J Cancer Surviv       Date:  2016-05-05       Impact factor: 4.442

3.  Improving Access to Integrative Oncology Through Group Medical Visits: A Pilot Implementation Project.

Authors:  Ariana Thompson-Lastad; Chloe E Atreya; Maria T Chao; Christine Pollak; Anand Dhruva; Trilce Santana; Donald I Abrams
Journal:  J Altern Complement Med       Date:  2019-07       Impact factor: 2.579

4.  Group medical consultations in the follow-up of breast cancer: a randomized feasibility study.

Authors:  Annemiek Visser; Hanneke W M van Laarhoven; Paulien H M Govaert; Margrethe S Schlooz; Lisette Jansen; Thijs van Dalen; Judith B Prins
Journal:  J Cancer Surviv       Date:  2015-01-13       Impact factor: 4.442

5.  Integrated Care Planning for Cancer Patients: A Scoping Review.

Authors:  Anum Irfan Khan; Erin Arthurs; Sharon Gradin; Marnie MacKinnon; Jonathan Sussman; Vishal Kukreti
Journal:  Int J Integr Care       Date:  2017-11-13       Impact factor: 5.120

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.